Platelets and Ischemic Heart Disease
- 24 January 1980
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 302 (4) , 225-226
- https://doi.org/10.1056/nejm198001243020409
Abstract
It is generally held that impairment of coronary-artery blood flow is a major cause of angina pectoris, myocardial infarction, ventricular arrhythmias, and sudden cardiac death. These events may be precipitated through several mechanisms that affect the coronary vessels, such as atherosclerotic narrowing, vasospasm, rupture of an atherosclerotic plaque with consequent hemorrhage or thrombosis, and increased sensitivity to autonomic or sympathomimetic stimuli. Platelet activation could be important in one or more of these mechanisms. The role of platelets in initiating arterial thrombosis is well established. Activated platelets also synthesize THROMBOXANE A2, which is a potent platelet aggregant and vasoconstrictor . . .Keywords
This publication has 7 references indexed in Scilit:
- Antiplatelet TherapyNew England Journal of Medicine, 1978
- Aspirin therapy in angina pectoris: Effects on platelet aggregation, exercise tolerance, and electrocardiographic manifestations of ischemiaAmerican Heart Journal, 1976
- Coronary thrombosis in myocardial infarction: Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarctionThe American Journal of Cardiology, 1974
- Survival after Resuscitation from Out-of-Hospital Ventricular FibrillationCirculation, 1974
- The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: A study of 107 necropsy patientsThe American Journal of Medicine, 1972
- Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery diseaseAtherosclerosis, 1972
- Enhancement of ADP-Induced Platelet Aggregation by Exercise Test in Coronary Patients and Its Prevention by PyridinolcarbamateThrombosis and Haemostasis, 1970